Your browser doesn't support javascript.
loading
Therapeutically targeting type I interferon directly to XCR1+ dendritic cells reveals the role of cDC1s in anti-drug antibodies.
Noe, Paul; Wang, Joy H; Chung, Kyu; Cheng, Zhiyong; Field, Jessica J; Shen, Xiaomeng; Cortesio, Christa L; Pastuskovas, Cinthia V; Phee, Hyewon; Tarbell, Kristin V; Egen, Jackson G; Casbon, Amy-Jo.
Afiliación
  • Noe P; Oncology Research, Amgen Research, South San Francisco, CA, United States.
  • Wang JH; Oncology Research, Amgen Research, South San Francisco, CA, United States.
  • Chung K; Oncology Research, Amgen Research, South San Francisco, CA, United States.
  • Cheng Z; Oncology Research, Amgen Research, South San Francisco, CA, United States.
  • Field JJ; Pharmacokinetics and Drug Metabolism, Amgen Research, South San Francisco, CA, United States.
  • Shen X; Pharmacokinetics and Drug Metabolism, Amgen Research, South San Francisco, CA, United States.
  • Cortesio CL; Therapeutics Discovery, Amgen Research, South San Francisco, CA, United States.
  • Pastuskovas CV; Pharmacokinetics and Drug Metabolism, Amgen Research, South San Francisco, CA, United States.
  • Phee H; Oncology Research, Amgen Research, South San Francisco, CA, United States.
  • Tarbell KV; Oncology Research, Amgen Research, South San Francisco, CA, United States.
  • Egen JG; Oncology Research, Amgen Research, South San Francisco, CA, United States.
  • Casbon AJ; Oncology Research, Amgen Research, South San Francisco, CA, United States.
Front Immunol ; 14: 1272055, 2023.
Article en En | MEDLINE | ID: mdl-37942313

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Interferón Tipo I / Neoplasias Límite: Humans Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Interferón Tipo I / Neoplasias Límite: Humans Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos